Moderna, Inc. posts $1,862 million revenue in quarter ended Mar 31, 2023

Moderna, Inc. [MRNA] has reported $79 million profit for the fiscal quarter ending Mar 31, 2023 while the earnings for the same period were $0.19 per share.

Revenue for the quarter was $1,862 million with operating income of $366 million.

The Cambridge, Massachusetts (MA)-based company operating in the biological products, except diagnostic substances sector has total shareholders equity of $18,863 million.

Also read:

This is a developing story. Click here to receive updates.

------------

NewsInMinutes, an offering of 10kInfo, Inc., brings you news on the latest regulatory filings. Subscribe to additional news alerts here.